晚期和/或复发性宫颈癌的化疗
Chemotherapy for advanced and/or recurrent cervical cancer.
作者信息
Lahousen M, Pickel H, Tamussino K
出版信息
Arch Gynecol. 1987;240(4):247-52. doi: 10.1007/BF02134075.
PMID:2440389
Abstract
A combination of bleomycin, vincristine, mitomycin-C, and cisplatin was used to treat 39 patients with advanced and/or recurrent cervical cancer. Twenty patients showed an objective response (complete or partial) with a mean duration of 14.8 months. The overall response rate was 58.8%. Twelve patients are still alive and in remission 7-36 months after the start of chemotherapy. Toxicity was acceptable.
摘要
采用博来霉素、长春新碱、丝裂霉素-C和顺铂联合治疗39例晚期和/或复发性宫颈癌患者。20例患者出现客观缓解（完全缓解或部分缓解），平均缓解持续时间为14.8个月。总缓解率为58.8%。12例患者在化疗开始后7至36个月仍存活且处于缓解状态。毒性反应可接受。
Zotero 插件